News

GitLab Inc. (GTLB) is the provider of The DevOps platform, a single application that brings together development, operations, IT, security, and business teams to deliver desired business outcomes. GitLab has an expected revenue and earnings growth rate of 26% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 60 days. Gitlab’s shares gained 31% over the last three months compared with the S&P 500’s advance of 10.7%.

NeoGenomics, Inc. (NEO) is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.EPS estimates have been moving higher, with 2023 set to post a 71% increase and this year forecast to see another 78% rise. NeoGenomics’s shares gained 26.1% over the last three months compared with the S&P 500’s advance of 7.4%.

Zacks Names #1 Semiconductor Stock

It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.

With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.

See This Stock Now for Free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.